Sofia Caria

Sofia Caria

Auto-generated profile, based on publicly available information

Sofia Caria

Department of Biochemistry & Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2017 in Viruses
Verified
Journal Article
Open access
PDF file
Marc KvansakulMarc Kvansakul
Marc Kvansakul
SCSofia Caria
Sofia Caria
MHMark G Hinds
Mark G Hinds
Members of the B cell lymphoma-2 (Bcl-2) family are pivotal arbiters of mitochondrially mediated apoptosis, a process of fundamental importance during tissue development, homeostasis, and disease. At the structural and mechanistic level, the mammalian members of the Bcl-2 family are increasingly well understood, with their interplay ultimately deciding the fate of a cell. Dysregulation of Bcl-2-mediated apoptosis underlies a plethora of diseases, and numerous viruses have acquired homologs of Bcl-2 to subvert host cell apoptosis and autophagy to prevent premature death of an infected cell. Here we review the structural biology, interactions, and mechanisms of action of virus-encoded Bcl-2 proteins, and how they impact on host-virus interactions to ultimately enable successful establishment and propagation of viral infections.

6 July 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
MJMichael Järvå
Michael Järvå
TPThanh Kha Phan
Thanh Kha Phan
FLFung T Lay
Fung T Lay
SCSofia Caria
Sofia Caria
Marc KvansakulMarc Kvansakul
Marc Kvansakul
MHMark Hulett
Mark Hulett
Human β-defensin 2 permeabilizes and kills fungal cells by specifically targeting the important plasma membrane lipid PIP 2 .

15 March 2017 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
SBSuresh Banjara
Suresh Banjara
SCSofia Caria
Sofia Caria
LDLinda Dixon
Linda Dixon
MHMark G Hinds
Mark G Hinds
Marc KvansakulMarc Kvansakul
Marc Kvansakul
Programmed cell death is a tightly controlled process critical for the removal of damaged or infected cells. Pro- and antiapoptotic proteins of the Bcl-2 family are pivotal mediators of this process. African swine fever virus (ASFV) is a large DNA virus, the only member of the Asfarviridae family, and harbors A179L, a putative Bcl-2 like protein. A179L has been shown to bind to several proapoptotic Bcl-2 proteins; however, the hierarchy of binding and the structural basis for apoptosis inhibition are currently not understood. We systematically evaluated the ability of A179L to bind proapoptotic Bcl-2 family members and show that A179L is the first antiapoptotic Bcl-2 protein to bind to all major death-inducing mammalian Bcl-2 proteins. We then defined the structural basis for apoptosis inhibition of A179L by determining the crystal structures of A179L bound to both Bid and Bax BH3 motifs. Our findings provide a mechanistic understanding for the potent antiapoptotic activity of A179L by identifying it as the first panprodeath Bcl-2 binder and serve as a platform for more-detailed investigations into the role of A179L during ASFV infection. IMPORTANCE Numerous viruses have acquired strategies to subvert apoptosis by encoding proteins capable of sequestering proapoptotic host proteins. African swine fever virus (ASFV), a large DNA virus and the only member of the Asfarviridae family, encodes the protein A179L, which functions to prevent apoptosis. We show that A179L is unusual among antiapoptotic Bcl-2 proteins in being able to physically bind to all core death-inducing mammalian Bcl-2 proteins. Currently, little is known regarding the molecular interactions between A179L and the proapoptotic Bcl-2 members. Using the crystal structures of A179L bound to two of the identified proapoptotic Bcl-2 proteins, Bid and Bax, we now provide a three-dimensional (3D) view of how A179L sequesters host proapoptotic proteins, which is crucial for subverting premature host cell apoptosis.

30 December 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LALuke A. Adams
Luke A. Adams
PSPooja Sharma
Pooja Sharma
BMBiswaranjan Mohanty
Biswaranjan Mohanty
OIOlga V. Ilyichova
Olga V. Ilyichova
MMMark D. Mulcair
Mark D. Mulcair
MSMartin J. Scanlon
Martin J. Scanlon

12 March 2015 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
BMB Marshall
B Marshall
HPH Puthalakath
H Puthalakath
SCS Caria
S Caria
SCS Chugh
S Chugh
MDM Doerflinger
M Doerflinger
Marc KvansakulMarc Kvansakul
Marc Kvansakul
Subversion of host cell apoptosis is an important survival strategy for viruses to ensure their own proliferation and survival. Certain viruses express proteins homologous in sequence, structure and function to mammalian pro-survival B-cell lymphoma 2 (Bcl-2) proteins, which prevent rapid clearance of infected host cells. In vaccinia virus (VV), the virulence factor F1L was shown to be a potent inhibitor of apoptosis that functions primarily be engaging pro-apoptotic Bim. Variola virus (VAR), the causative agent of smallpox, harbors a homolog of F1L of unknown function. We show that VAR F1L is a potent inhibitor of apoptosis, and unlike all other characterized anti-apoptotic Bcl-2 family members lacks affinity for the Bim Bcl-2 homology 3 (BH3) domain. Instead, VAR F1L engages Bid BH3 as well as Bak and Bax BH3 domains. Unlike its VV homolog, variola F1L only protects against Bax-mediated apoptosis in cellular assays. Crystal structures of variola F1L bound to Bid and Bak BH3 domains reveal that variola F1L forms a domain-swapped Bcl-2 fold, which accommodates Bid and Bak BH3 in the canonical Bcl-2-binding groove, in a manner similar to VV F1L. Despite the observed conservation of structure and sequence, variola F1L inhibits apoptosis using a startlingly different mechanism compared with its VV counterpart. Our results suggest that unlike during VV infection, Bim neutralization may not be required during VAR infection. As molecular determinants for the human-specific tropism of VAR remain essentially unknown, identification of a different mechanism of action and utilization of host factors used by a VAR virulence factor compared with its VV homolog suggest that studying VAR directly may be essential to understand its unique tropism.

1 April 2009 in Structure
Verified
Journal Article
Closed access
JTJoanna Timmins
Joanna Timmins
EGElspeth Gordon
Elspeth Gordon
SCSofia Caria
Sofia Caria
GLGordon Leonard
Gordon Leonard
SASamira Acajjaoui
Samira Acajjaoui
SMSean McSweeney
Sean McSweeney